ask="39.18"
ask_size="100"
average_daily_volume="1414130"
bid="38.00"
bid_size="600"
book_value="11.83"
change="+0.57"
change_from_200_day_moving_average="-15.99"
change_from_50_day_moving_average="-2.35"
change_from_52_week_high="-41.11"
change_From_52_week_low="7.70"
change_in_percent="+1.48%"
close="39.08"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.82"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="39.74"
high_52_weeks="80.19"
last_trade_date="1/19/2017"
last_trade_price="39.08"
last_trade_size="39584"
last_trade_time="4:00pm"
low="38.06"
low_52_weeks="31.38"
market_capitalization="3.35B"
moving_average_200_day="55.07"
moving_average_50_day="41.43"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="63.36"
open="38.50"
pe_ratio="N/A"
peg_ratio="-0.17"
percent_change_from_200_day_moving_average="-29.04%"
percent_change_from_50_day_moving_average="-5.67%"
percent_change_from_52_week_high="-51.27%"
percent_change_from_52_week_low="+24.54%"
previous_close="38.51"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.25"
price_per_sales="88.70"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.47"
stock_exchange="NMS"
symbol="ALNY"
volume="1579562"
weeks_range_52="31.38 - 80.19"
